Truist Securities Initiates Coverage On Organogenesis Holdings with Hold Rating, Announces Price Target of $3
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Truist Securities analyst Ravi Misra initiates coverage on Organogenesis Holdings (NASDAQ:ORGO) with a Hold rating and announces Price Target of $3.
Truist Securities analyst Ravi Misra initiates coverage on Organogenesis Holdings (NASDAQ:ORGO) with a Hold rating and announces Price Target of $3.